Icon

BRIXADI (nda210136)- (8MG/0.16ML (50MG/ML))

BUPRENORPHINE BRAEBURN
8MG/0.16ML (50MG/ML)
No Yes
2032-Jul-26 Expired
None 2026-May-23
None No
BRIXADI contains buprenorphine, a partial opioid agonist. BRIXADI is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. BRIXADI should be used as part of a complete treatment plan that includes counseling and psychosocial support.
0 0 0
Total Other Developers None
Drugs with Suitability No
8MG/0.16ML (50MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.